Track: Drug Design and Clinical Trials

Drug Design and Clinical Trials


The process of developing or discovering innovative medicines based on biological targets is known as drug design. The medicine, which is a small chemical, affects biomolecules by boosting or inhibiting function, giving people a positive effect. The drug should be formulated to be complimentary to the target in shape and charge in order to interact and bind with the receptor. It might be completely computerised, or it could be aided by medication design. This is useful in the search for or development of medications utilising computational methodologies, which can be selected based on improved affinity, stability, and selectivity.

Clinical trials are the culmination of a long procedure that starts in a research centre. It's a study endeavour that relies on volunteers. After years of research to understand its effects on cancer cells in the lab and in animals, a novel medicine is being tested on people in clinical trials. Clinical trials help doctors find better medications and prevent cancer and other diseases by allowing them to test new ideas. They also respond to other questions, such as how to avoid illness or manage symptoms and side effects.